| 23.01.2024 07:00 | OVB | Holding(s) in Company | RNS |
| 01.12.2023 12:00 | OVB | Result of AGM | RNS |
| 23.11.2023 15:53 | RICA, RFG, RBG | UK shareholder meetings calendar - next 7 days | Alliance |
| 07.11.2023 09:15 | OVB | Notice of AGM | RNS |
| 28.09.2023 14:41 | WRKS, LND, KLSO | EARNINGS: Ovoca "to adapt" after study let-down, Kelso NAV rises | Alliance |
| 28.09.2023 07:00 | OVB | Interim Results | RNS |
| 31.08.2023 12:08 | OVB | Ovoca Bio shares dive following disappointing Orenetide study results | Alliance |
| 31.08.2023 10:43 | ETP, OVB, KOD | AIM WINNERS & LOSERS: Ovoca Bio plunges on disappointing study results | Alliance |
| 31.08.2023 07:00 | OVB | Summary Results of Phase II Study for Orenetide | RNS |
| 30.06.2023 17:26 | AMC, PHE, DCI | EARNINGS SUMMARY: Powerhouse loss widens hugely, DCI Advisors narrows | Alliance |
| 30.06.2023 07:00 | OVB | Annual Financial Report | RNS |
| 12.06.2023 10:13 | OVB, TUN, FUM | AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed | Alliance |
| 12.06.2023 09:01 | OVB | Ovoca Bio shares down as study delayed due to staffing issues | Alliance |
| 12.06.2023 07:00 | OVB | Update on Completion Timelines for Phase II Study | RNS |
| 16.03.2023 16:35 | OVB | Price Monitoring Extension | RNS |
| 16.03.2023 14:05 | OVB | Second Price Monitoring Extn | RNS |
| 16.03.2023 14:00 | OVB | Price Monitoring Extension | RNS |
| 16.03.2023 09:05 | OVB | Second Price Monitoring Extn | RNS |
| 16.03.2023 09:00 | OVB | Price Monitoring Extension | RNS |
| 08.03.2023 14:21 | OVB | IN BRIEF: Ovoca Bio jumps on EUR1.1 million sale of Russian assets | Alliance |
| 08.03.2023 07:00 | OVB | Disposal of Russian Assets | RNS |
| 14.02.2023 16:41 | OVB | Second Price Monitoring Extn | RNS |
| 14.02.2023 16:35 | OVB | Price Monitoring Extension | RNS |
| 14.02.2023 14:05 | OVB | Second Price Monitoring Extn | RNS |
| 14.02.2023 14:00 | OVB | Price Monitoring Extension | RNS |
| 13.02.2023 09:00 | OVB | Price Monitoring Extension | RNS |
| 13.01.2023 11:05 | OVB | Second Price Monitoring Extn | RNS |
| 13.01.2023 11:00 | OVB | Price Monitoring Extension | RNS |
| 28.10.2022 07:00 | OVB | Result of AGM | RNS |
| 20.10.2022 15:58 | SHIP, WRKS, S32 | UK shareholder meetings calendar - next 7 days | Alliance |
| 06.10.2022 17:18 | MODE, AGTA, GPL | TRADING UPDATES: Nostra revenue rises; Synergia eyes Cambay farm-out | Alliance |
| 06.10.2022 17:17 | MODE, AGTA, GPL | TRADING UPDATES: Nostra revenue rises; Synergia eyes Cambay farm-out | Alliance |
| 06.10.2022 17:17 | MODE, AGTA, GPL | TRADING UPDATES: Nostra revenue rises; Synergia eyes Cambay farm-out | Alliance |
| 06.10.2022 14:30 | OVB | Notice of AGM | RNS |
| 30.09.2022 07:00 | OVB | Interim Results | RNS |
| 29.07.2022 19:36 | SYN, SYME, OVB | TRADING UPDATES: Walker Crips assets grow; Minoan interim loss narrows | Alliance |
| 29.07.2022 07:00 | OVB | Completion of Enrollment in Phase II Study | RNS |
| 30.06.2022 12:17 | SPDI, GRIO, KRPZ | EARNINGS UPDATES: Live Co revenue rises; Ovoca cautions on Russia | Alliance |
| 30.06.2022 07:00 | OVB | Annual Financial Report | RNS |
| 07.03.2022 09:00 | OVB | Statement re Russian Business Operations | RNS |
| 23.02.2022 16:41 | OVB | Second Price Monitoring Extn | RNS |
| 23.02.2022 16:36 | OVB | Price Monitoring Extension | RNS |
| 22.02.2022 21:57 | PYX, CBA, UJO | TRADING UPDATES: Angling Direct ups revenue; Ceiba takes Omicron hit | Alliance |
| 22.02.2022 15:30 | OVB | Russian Marketing Authorisation for Orenetide | RNS |
| 31.01.2022 07:00 | OVB | Board Changes and Update | RNS |
| 30.12.2021 07:00 | OVB | Directorate Change | RNS |
| 04.11.2021 15:53 | OVB | Holding(s) in Company | RNS |
| 04.11.2021 15:50 | OVB | Director/PDMR Shareholding | RNS |
| 04.11.2021 15:46 | OVB | Board Change | RNS |
| 14.09.2021 07:00 | OVB | Interim Results | RNS |
| 29.07.2021 17:00 | OVB | Result of AGM | RNS |
| 24.06.2021 07:00 | OVB | Annual Report and Notice of AGM | RNS |
| 10.03.2021 07:00 | OVB | Migration of Participating Securities | RNS |
| 16.02.2021 14:00 | OVB | Result of EGM | RNS |
| 29.01.2021 07:00 | OVB | First Patient Enrolled in Phase II Study - BP-101 | RNS |
| 25.01.2021 15:30 | OVB | Notice of EGM | RNS |
| 05.01.2021 07:00 | OVB | Re-Filing of Marketing Authorisation Application | RNS |
